Process for the preparation of pyridine heterocycle CGRP antagonist intermediate

Details for Australian Patent Application No. 2007238894 (hide)

Owner Merck & Co., Inc.

Inventors Palucki, Michael; McLaughlin, Mark; Marcantonio, Karen

Agent Spruson & Ferguson

Pub. Number AU-A-2007238894

PCT Pub. Number WO2007/120590

Priority 60/790,702 10.04.06 US

Filing date 6 April 2007

Wipo publication date 25 October 2007

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

9 October 2008 PCT application entered the National Phase

  PCT publication WO2007/120590 Priority application(s): WO2007/120590

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

1 November 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007238895-Process for the preparation of CGRP antagonist

2007238893-Process for the preparation of caprolactam CGRP antagonist intermediate